Table 1.

Overview of the COVID-19 vaccine research landscape and evidence from Africa: preclinical studies^a

Country	Developer	Vaccine Platform
Egypt	National Research Centre	DNA based
Egypt	National Research Centre	Inactivated whole virus
Egypt	National Research Centre	Non replicating viral vector (Influenza A H1N1)
Egypt	National Research Centre	Protein Subunit S, N, M&S1 protein
Nigeria	Helix Biogen Consult	Protein Subunit (S), E. coli based expression

^aReferenced from WHO COVID-19 candidate vaccine landscape and tracker (version of 30^th April 2021)